Recent findings from the Chinese University of Hong Kong (CUHK) show that one out of five non-obese individuals suffer from non-alcoholic fatty liver disease (NAFLD). Liver biopsy studies further reveal high rates of steatohepatitis and severe liver fibrosis in non-obese NAFLD patients.
Long-term use of oral nucleos(t)ide analogues (NAs) in patients with chronic hepatitis B (CHB) infection does not increase cancer risk, a recent large population-based study has shown.
A novel, multi-gene, RNA-based molecular signature can detect circulating tumour cells from hepatocellular carcinomas with high specificity and sensitivity, a new study claims.
The use of statins is associated with a lower risk of pyogenic liver abscess, according to a Taiwan population-based case-control study.
Statin therapy may reduce the risk of cirrhosis and its associated comorbidities in chronic hepatitis B (CHB) patients, according to a presentation at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL) Annual Meeting 2017 held in Shanghai, China.